Felbamate
Back to searchMolecule Structure
Scientific Name
Felbamate
Description of the Drug
Felbamate is an anticonvulsant used to treat severe epilepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00949
http://www.drugbank.ca/drugs/DB00949
Brand Name(s)
Felbamate, Felbatol, Taloxa
Company Owner(s)
Cadila Healthcare Ltd, Mylan Specialty Lp, Alvogen Inc, Amneal Pharmaceuticals, Ani Pharmaceuticals Inc, Taro Pharmaceutical Industries Ltd, Novitium Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glutamate [NMDA] receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2094124 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34947 | |
| PharmGKB | PA449590 | |
| Human Metabolome Database | HMDB0015084 | |
| DrugBank | DB00949 | |
| PubChem: Thomson Pharma | 15196364 | |
| PubChem | 3331 | |
| Mcule | MCULE-2661497722 | |
| LINCS | LSM-4232 | |
| Nikkaji | J50.906J | |
| BindingDB | 50088430 | |
| EPA CompTox Dashboard | DTXSID9023041 | |
| DrugCentral | 1140 | |
| ChemicalBook | CB6689427 | |
| Guide to Pharmacology | 5473 | |
| rxnorm | FELBAMATE | FELBATOL |
| PubChem: Drugs of the Future | 12013710 | |
| KEGG Ligand | C07501 | |
| ChEBI | 4995 | |
| ZINC | ZINC000001530803 |
